Filters

Latest News

2020-06-04 13:02:10

Pharma pledges to continue 20 year partnership with Gavi, the Vaccine Alliance

IFPMA members have worked for 20 years with Gavi to stem the ravages of childhood infectious diseases, helping vaccinate an ...

Read More

2020-05-28 15:00:58

Pharma partners in efforts to give coronavirus vaccine for everyone

Geneva, 28 May 2020. IFPMA has today updated the world’s media on the biopharmaceutical industry’s ...

Read More

2020-05-28 08:04:20

Pharma industry updates advice on engaging with healthcare professionals as countries emerge from COVID-19 lockdown

Geneva, 28 May 2020: As countries lift lockdown restrictions, the international pharma industry body, IFPMA, ...

Read More

2020-05-19 15:31:26

Pharma and other innovative health groups tell World Health Assembly it stands united with governments and global health stakeholders worldwide to combat COVID-19

Geneva, May 19, 2020: At the Seventy-Third World Health Assembly, IFPMA, the industry body representing ...

Read More

2020-05-04 16:28:01

Pharma Joins Global Pledge Committing to Work Together to Beat COVID-19

Geneva, 4 May, 2020: The world’s leading biopharmaceutical companies today reaffirmed the industry’s commitment to ...

Read More

2020-04-30 15:25:13

Global Pharma update on unprecedented efforts to collaborate in speeding up the search for safe and effective COVID-19 therapies

Geneva, April 30, 2020: R&D biopharmaceutical companies have brought together their best people, resources and ...

Read More

2020-04-24 14:43:32

Pharma industry body joins as founding partner a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools

Geneva, April 24, 2020: The world’s leading biopharmaceutical companies proclaimed their commitment to a landmark ...

Read More

Latest Statement

2020-06-04 13:01:49

Biopharmaceutical Industry Statement at Gavi, the Vaccine Alliance – Global Vaccine Summit 2020

Geneva, 4 June 2020 Statement delivered by: Thomas Cueni, Director General of IFPMA, the International Federation of Pharmaceutical Manufacturers and ...

Read More

2020-05-28 19:14:41

IFPMA Statement on the “Solidarity Call to Action to realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property and data”

Geneva, April 24, 2020: The world’s leading biopharmaceutical companies proclaimed ...

Read More

2020-05-28 08:01:08

Ethical Considerations for Resuming In-Person Interactions with Healthcare Professionals Post COVID-19: A Guidance Document

Geneva, April 24, 2020: The world’s leading biopharmaceutical companies proclaimed ...

Read More

2020-05-18 08:01:23

Joint Statement – Innovative Health Industries @ WHA73

Geneva, April 24, 2020: The world’s leading biopharmaceutical companies proclaimed ...

Read More

2020-05-14 12:55:19

COVID-19 Biopharmaceutical Industry – Regulatory Guiding Principles

Geneva, April 24, 2020: The world’s leading biopharmaceutical companies proclaimed ...

Read More

2020-05-04 16:23:13

Pharma Statement for The Coronavirus Global Response Pledging Marathon

Geneva, April 24, 2020: The world’s leading biopharmaceutical companies proclaimed ...

Read More

2020-04-24 13:41:50

IFPMA Statement on the launch of a new global collaboration to accelerate the development, production and equitable access to new COVID-19 tools

Geneva, April 24, 2020: The world’s leading biopharmaceutical companies proclaimed ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

RT @DrCaryAdams: At the @gavi Vaccine summit @ThomasCueni @IFPMA commits the pharmaceutical industry to find a #vaccine for #COVID19 quickl…
2
RT @sanofipasteur: As @gavi marks its 20th anniversary, we reaffirm our commitment to #ProtectTheNextGeneration from serious infectious dis…
7
RT @pfizer: We are proud to have joined #GenerationGavi 10 years ago, and we are committed to doing our part to protect the next generation…
5
RT @sanofipasteur: Along with @gavi and other @IFPMA members, we have made significant investments towards multi-year immunization projects…
1
RT @AEV_Vacunas: La declaración de la Federación Internacional de Fabricantes y Asociaciones Farmacéuticas @IFPMA respecto a las #vacunas f…
1